Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor von Kaye, Joel, Piryatinsky, Victor, Birnberg, Tal, Hingaly, Tal, Raymond, Emanuel, Kashi, Rina, Amit-Romach, Einat, Caballero, Ignacio S., Towfic, Fadi, Ator, Mark A., Rubinstein, Efrat, Laifenfeld, Daphna, Orbach, Aric, Shinar, Doron, Marantz, Yael, Grossman, Iris, Knappertz, Volker, Hayden, Michael R., Laufer, Ralph

Volltext

CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis von Comi, Giancarlo, Dadon, Yuval, Sasson, Nissim, Steinerman, Joshua R, Knappertz, Volker, Vollmer, Timothy L, Boyko, Alexey, Vermersch, Patrick, Ziemssen, Tjalf, Montalban, Xavier, Lublin, Fred D, Rocca, Maria A, Volkinshtein, Rita, Rubinchick, Svetlana, Halevy, Nitsan, Filippi, Massimo

Volltext

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study von O'Connor, Paul, MD, Filippi, Massimo, MD, Arnason, Barry, MD, Comi, Giancarlo, MD, Cook, Stuart, MD, Goodin, Douglas, MD, Hartung, Hans-Peter, MD, Jeffery, Douglas, MD, Kappos, Ludwig, MD, Boateng, Francis, PhD, Filippov, Vitali, PhD, Groth, Maria, MD, Knappertz, Volker, MD, Kraus, Christian, MD, Sandbrink, Rupert, MD, Pohl, Christoph, MD, Bogumil, Timon, MD

Volltext

Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS von Bovis, Francesca, De Stefano, Nicola, Steinerman, Joshua R, Knappertz, Volker, Sormani, Maria Pia

Volltext

Causes of death among commercially insured multiple sclerosis patients in the United States von Goodin, Douglas S, Corwin, Michael, Kaufman, David, Golub, Howard, Reshef, Shoshana, Rametta, Mark J, Knappertz, Volker, Cutter, Gary, Pleimes, Dirk

Volltext

A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis von Ross, Colin J, Towfic, Fadi, Shankar, Jyoti, Laifenfeld, Daphna, Thoma, Mathis, Davis, Matthew, Weiner, Brian, Kusko, Rebecca, Zeskind, Ben, Knappertz, Volker, Grossman, Iris, Hayden, Michael R

Volltext

Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS von Goodin, Douglas S, Jones, Jason, Li, David, Traboulsee, Anthony, Reder, Anthony T, Beckmann, Karola, Konieczny, Andreas, Knappertz, Volker

Volltext

Sample Size Estimates for Clinical Trials of Vasospasm in Subarachnoid Hemorrhage von KREITER, Kurt T, MAYER, Stephan A, HOWARD, George, KNAPPERTZ, Volker, ILODIGWE, Don, SLOAN, Michael A, MACDONALD, R. Loch

Volltext

Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial von Watkins, Paul B., Church, Rachel J., Li, Jie, Knappertz, Volker

Volltext

Potential Health Care Cost Savings Associated With Early Treatment of Multiple Sclerosis Using Disease-Modifying Therapy von Curkendall, Suellen M., PhD, Wang, Cheng, MD, PhD, Johnson, Barbara H., MBA, Cao, Zhun, PhD, Preblick, Ronald, PharmD, MPH, Torres, Amelito M., MBA, Knappertz, Volker, MD, Gondek, Kathleen, PhD

Volltext

An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration von Fisher, Matt, PharmD, Cushman, Mary, MD, MSc, Knappertz, Volker, MD, Howard, George, DrPH

Volltext

Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial von Miller, Ian, Scheffer, Ingrid E, Gunning, Boudewijn, Sanchez-Carpintero, Rocio, Gil-Nagel, Antonio, Perry, M. Scott, Saneto, Russell P, Checketts, Daniel, Dunayevich, Eduardo, Knappertz, Volker

Volltext

Mortality in patients with multiple sclerosis von Scalfari, Antonio, Knappertz, Volker, Cutter, Gary, Goodin, Douglas S, Ashton, Raymond, Ebers, George C

Volltext

Once‐daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing–remitting multiple sclerosis von Yamamura, Takashi, Ashtamker, Natalia, Ladkani, David, Fukazawa, Toshiyuki, Houzen, Hideki, Tanaka, Masami, Miura, Toshiro, Knappertz, Volker

Volltext

Challenges and opportunities in designing clinical trials for neuromyelitis optica von Weinshenker, Brian G., Barron, Gerard, Behne, Jacinta M., Bennett, Jeffery L., Chin, Peter S., Cree, Bruce A.C., de Seze, Jerome, Flor, Armando, Fujihara, Kazuo, Greenberg, Benjamin, Higashi, Sayumi, Holt, William, Khan, Omar, Knappertz, Volker, Levy, Michael, Melia, Angela T., Palace, Jacqueline, Smith, Terry J., Sormani, Maria Pia, Van Herle, Katja, VanMeter, Susan, Villoslada, Pablo, Walton, Marc K., Wasiewski, Warren, Wingerchuk, Dean M., Yeaman, Michael R.

Volltext

Pharmacodynamic synergism contributes to the antiseizure action of cannabidiol and clobazam von Rana, Rohini R., Rajasekaran, Karthik, Knappertz, Volker, Gray, Royston A.

Volltext

The dose of aspirin for the prevention of cardiovascular and cerebrovascular events von Fisher, Matt, Knappertz, Volker

Volltext

Early impairment in consciousness predicts mortality after hemispheric ischemic stroke von CUCCHIARA, Brett L, KASNER, Scott E, WOLK, David A, LYDEN, Patrick D, KNAPPERTZ, Volker A, ASHWOOD, Tim, ODERGREN, NORDLUND, Anders

Volltext

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis von Caloyeras, John P., MPhil, Zhang, Bin, MD, MSc, Wang, Cheng, MD, PhD, Eriksson, Marianne, MSc, Fredrikson, Sten, MD, PhD, Beckmann, Karola, MSc, Knappertz, Volker, MD, Pohl, Christoph, MD, Hartung, Hans-Peter, MD, Shah, Dhvani, MS, Miller, Jeffrey D., MS, Sandbrink, Rupert, MD, Lanius, Vivian, PhD, Gondek, Kathleen, PhD, Russell, Mason W., MAPE

Volltext

Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials von Devinsky, Orrin, Thiele, Elizabeth A, Wright, Stephen, Checketts, Daniel, Morrison, Gilmour, Dunayevich, Eduardo, Knappertz, Volker

Volltext